Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α

被引:887
作者
Fu, J
Gaetani, S
Oveisi, F
Lo Verme, J
Serrano, A
de Fonseca, FR
Rosengarth, A
Luecke, H
Di Giacomo, B
Tarzia, G
Piomelli, D [1 ]
机构
[1] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA
[2] Fdn Hosp Carlos Haya, Malaga, Spain
[3] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA
[4] Univ Urbino, Inst Med Chem, I-61029 Urbino, Italy
关键词
D O I
10.1038/nature01921
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oleylethanolamide (OEA) is a naturally occurring lipid that regulates satiety and body weight(1,2). Although structurally related to the endogenous cannabinoid anandamide, OEA does not bind to cannabinoid receptors and its molecular targets have not been defined. Here we show that OEA binds with high affinity to the peroxisome-proliferator-activated receptor-alpha (PPAR-alpha), a nuclear receptor that regulates several aspects of lipid metabolism. Administration of OEA produces satiety and reduces body weight gain in wild-type mice, but not in mice deficient in PPAR-alpha. Two distinct PPAR-alpha agonists have similar effects that are also contingent on PPAR-alpha expression, whereas potent and selective agonists for PPAR-gamma and PPAR-beta/delta are ineffective. In the small intestine of wild-type but not PPAR-alpha-null mice, OEA regulates the expression of several PPAR-alpha target genes: it initiates the transcription of proteins involved in lipid metabolism and represses inducible nitric oxide synthase, an enzyme that may contribute to feeding stimulation. Our results, which show that OEA induces satiety by activating PPAR-alpha, identify an unexpected role for this nuclear receptor in regulating behaviour, and raise possibilities for the treatment of eating disorders.
引用
收藏
页码:90 / 93
页数:4
相关论文
共 30 条
  • [1] Peroxisome proliferator-activated receptor-α regulates lipid homeostasis, but is not associated with obesity -: Studies with congenic mouse lines
    Akiyama, TE
    Nicol, CJ
    Fievet, C
    Staels, B
    Ward, JM
    Auwerx, J
    Lee, SST
    Gonzalez, FJ
    Peters, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) : 39088 - 39093
  • [2] The mechanisms of action of PPARs
    Berger, J
    Moller, DE
    [J]. ANNUAL REVIEW OF MEDICINE, 2002, 53 : 409 - 435
  • [3] Best JD, 2001, EXPERT OPIN INV DRUG, V10, P1901
  • [4] BROWN PJ, 2000, Patent No. 32
  • [5] Butler A A, 2001, Trends Genet, V17, pS50, DOI 10.1016/S0168-9525(01)02481-7
  • [6] CIGLITAZONE, A NEW HYPOGLYCEMIC AGENT .1. STUDIES IN OB/OB AND DB/DB MICE, DIABETIC CHINESE HAMSTERS, AND NORMAL AND STREPTOZOTOCIN-DIABETIC RATS
    CHANG, AY
    WYSE, BM
    GILCHRIST, BJ
    PETERSON, T
    DIANI, AR
    [J]. DIABETES, 1983, 32 (09) : 830 - 838
  • [7] CHAO EYH, 2001, Patent No. 83
  • [8] Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight
    Chaput, E
    Saladin, R
    Silvestre, M
    Edgar, AD
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 271 (02) : 445 - 450
  • [9] Nuclear receptors and lipid physiology: Opening the X-files
    Chawla, A
    Repa, JJ
    Evans, RM
    Mangelsdorf, DJ
    [J]. SCIENCE, 2001, 294 (5548) : 1866 - 1870
  • [10] EFFECT OF LONG-TERM CLOFIBRIC ACID TREATMENT ON SERUM AND TISSUE LIPID AND CHOLESTEROL LEVELS IN OBESE ZUCKER RATS
    CLEARY, MP
    KASISKE, B
    ODONNELL, MP
    KEANE, WF
    [J]. ATHEROSCLEROSIS, 1987, 66 (1-2) : 107 - 112